PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11743742-6	2001	Remarkably, we have also identified several compounds-valinomycin, norverapamil, reserpine, nobiletin, emetine, gallopamil, fluphenazine-that uniquely inhibit P-gp function with affinities comparable to benchmark P-gp inhibitors despite a lack of effect on CYP3A4 function at physiologically relevant concentrations.	Reserpine	81-90	phosphoglycolate phosphatase	Homo sapiens	159-163	
11743742-6	2001	Remarkably, we have also identified several compounds-valinomycin, norverapamil, reserpine, nobiletin, emetine, gallopamil, fluphenazine-that uniquely inhibit P-gp function with affinities comparable to benchmark P-gp inhibitors despite a lack of effect on CYP3A4 function at physiologically relevant concentrations.	Reserpine	81-90	phosphoglycolate phosphatase	Homo sapiens	213-217	
11743742-8	2001	Additionally, norverapamil and reserpine have, respectively, a 60- and 40-fold preference for inhibition of P-gp over CYP3A4.	Reserpine	31-40	phosphoglycolate phosphatase	Homo sapiens	108-112	
9380755-8	1997	Sensitivity was restored by the Pgp inhibitor reserpine, demonstrating that only drug retention was the basis for loss of drug sensitivity.	Reserpine	46-55	phosphoglycolate phosphatase	Homo sapiens	32-35	
9111066-1	1997	The P-glycoprotein (Pgp) reversing agent, reserpine, induces MDR1 mRNA and PGP protein in human colon carcinoma cells (Schuetz, E. G., Beck, W. T., and Schuetz, J. D. (1996) Mol.	Reserpine	42-51	phosphoglycolate phosphatase	Homo sapiens	75-78	
7737146-2	1995	We show here that the chemosensitizers, reserpine and verapamil, display a dramatic potentiation of taxol, anthracycline and Vinca alkaloids cytotoxicity in P-glycoprotein-(P-gp)-deficient hamster and human nasopharyngeal carcinoma cells.	Reserpine	40-49	phosphoglycolate phosphatase	Homo sapiens	173-177